COLLINS HELEN LOUISE (CHIEF MEDICAL OFFICER) sold 61.5% of their position (40K shares) of ENLIVEN THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.40M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/27/2026ACC: 0001701247-26-000005
Officer· CHIEF MEDICAL OFFICER
Since Feb 2026
-40K
Net shares
Net seller
$1.40M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
40K acquired · 80K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+40K
Price / share
$2.48
Trade value
$99.20K
% of position
160.0%
3/25/2026
25K→65K
Common Stock
Direct
Shares
−40K
Price / share
$35.10
Trade value
$1.40M
% of position
61.5%
3/25/2026
65K→25K
Total
Net shares
+0.00
Net value
-$1.30M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/25/2026 | M · Option Exercise | +40K | $2.48 | $99.20K | 160.0% | 25K | 65K |
| Common Stock Direct | 3/25/2026 | S · Sale | −40K | $35.10 | $1.40M | 61.5% | 65K | 25K |
| Total | +0.00 | -$1.30M | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
40K shares
Shares
−40K
Strike price
2.48
Held after
136.27K
Exercisable
—
3/25/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock40K shares | 3/25/2026 | M · Option Exercise | −40K | 2.48 | — | 136.27K |